Seqirus offers one of the most comprehensive portfolios of influenza products all year round.

Flaud Logo

The first FDA-approved seasonal influenza vaccine made with MF59®, an immune-enhancing adjuvant proven to help provide a strong immune response to influenza for adults 65 and older.1,2


The first and only cell-based quadrivalent influenza vaccine in the US that offers prevention against 4 influenza strains – virus subtypes A and type B contained within the vaccine -for people 4 years and older.3,4

Afluria Logo

A quadrivalent influenza vaccine for people 6 months and older manufactured through the traditional egg-based process.5

Rapivab Logo

The first full course of antiviral influenza therapy in a single intravenous (IV) dose for people 2 years and older. RAPIVABTM helps treat acute uncomplicated influenza in patients who have been symptomatic for no more than 2 days with one 15- to 30-minute IV infusion.6


  1. FLUAD [package insert]. Holly Springs, NC: Seqirus Inc; 2018.
  2. Centers for Disease Control and Prevention. Flu vaccine with adjuvant, brand name FLUAD. Updated October 18, 2018. Accessed
    October 24,2018.
  3. FLUCELVAX QUADRIVALENT [package insert]. Holly Springs, NC: Seqirus Inc; 2018.
  4. Centers for Disease Control and Prevention. Cell-based flu vaccines. Last updated October 4, 2018.
    Accessed October 24, 2018.
  5. AFLURIA QUADRIVALENT [package insert]. Summit, NJ: Seqirus USA Inc; 2018.
  6. RAPIVAB [package insert]. Durham, NC: BioCryst Pharmaceuticals, Inc; 2018.


By creating an account with us, you can see specific product
pricing, make a purchase, and manage your shipments easily.